Purdue Institute for Drug Discovery

Canine PD-L1

Overview: 

Canine PD-L1 is an antibody immunotherapy that has been tested in a syngeneic bladder cancer mouse model.

Status: 

Purdue Faculty: 

Dr. Seung-Oe Lim